Primer on Urology -

. .

Résumé :
Presents all basic elements of Urology Based on the latest evidence-based guidelines Combines the European and American approach Written by key opinion leaders...

Biographie:

Christopher R. Chapple is an Emeritus Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at the University of Sheffield, and Visiting Professor at Sheffield Hallam University. He is particularly interested in the functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms and provided an NHS tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital, where he completed his doctorate thesis. He continued there and at the Institute of Urology in London for his sub-specialist training. He was Secretary General of the European Association of Urology 2015-2023, having previously been Chairman of the International Relations Committee, Adjunct Secretary General Responsible for Education, and Director of the European School of Urology. He was the Network Coordinator for the European Reference Network (ERN) for rare urogenital diseases and complex conditions (eUROGEN) from 2016-2019. He was the editor-in-chief of the journal Neurourology & Urodynamics from 2006-2016 and is on the editorial board of several international journals. He is an active member of many urological associations and societies and has been awarded honorary membership of 25 national urological associations. He has honorary fellowships from the Royal College of Surgeons Hong Kong, the Sri Lankan College of Surgeons, and the American College of Surgeons. He has chaired several guidelines initiatives, including the NICE GDG on Male LUTS and the ICUD Consultation on Male LUTS. BAUS awarded him the St Peter's medal in 2011, SUFU awarded him the Lifetime Achievement Award in 2015, the International Continence Society made him the inaugural member of their Hall of Fame in 2020, CAU awarded him the Shlomo Raz medal in 2022, and the SIU gave him a Distinguished Career Award in 2023. ...

Sommaire:

Part 1: Non muscle invasive bladder cancer.- Ch 1. Diagnosis and management of patients.- Ch 2. Adjuvant therapy.- Ch 3. TA, T1 and carcinoma in situ.- Part 2: Prostate cancer.- Ch 4. Screening and early detection.- Ch 5. Management of metastatic disease.- Ch 6. Epidemiology.- Ch 7. Local staging of prostate cancer.- Ch 8. Management of localized disease.- Ch 9. Management of high-risk and locally advanced disease.- Ch 10. Experimental therapies.- Part 3: Muscle invasive bladder cancer.- Ch 11. Diagnosis and management.- Ch 12. Evidence relating to surgical management.- Ch 13. Role of lymph node dissection.- Ch 14. Systemic chemotherapy and immunotherapy.- Part 4: Renal cell carcinoma.- Ch 15. Diagnosis and initial management.- Ch 16. Management of Locally Advanced RCC with IVC Tumor Thrombosis.- Ch 17. Metastatic.- Ch 18. Localised Renal Cell Carcinoma.- Part 5: Testicular cancer.- Ch 19. Testicular cancer: Diagnosis and Initial Management.- Ch 20. Extended surgery.- Ch 21. Chemotherapy.- Part 6: Penile cancer.- Ch 22. Penile Cancer: Epidemiology, Pathology and Carcinogenesis.- Ch 23. Conservative management and laser ablation of superficial disease.- Ch 24. Surgical management.- Ch 25. Imaging and management of lymph node involvement in penile squamous cell carcinoma.- Ch 26. Systemic treatment: Neoadjuvant, adjuvant adn palliative.- Part 7: Treatment of non-neurogenic male urinary tract symptoms.- Ch 27. Diagnosis.- Ch 28. Pharmacotherapy.- Ch 29. Established surgical interventions.- Ch 30. Emerging treatments for non-neurogenic male LUTS.- Part 8: Treatment of Non-Neurogenic Female Urinary Tract symptoms.- Ch 31. Treatment of Non - Neurogenic Female Urinary Tract Symptoms Diagnosis.- Ch 32. Conservative and Pharmacological Treatment.- Ch 33. Surgical Treatment.- Ch 34. New Surgical Treatments and Experimental Treatments.- Part 9: Treatment of Neurogenic Urinary Tract Symptoms In Both Sexes.- Ch 35. Treatment of Neurogenic Urinary Tract Symptoms In Both Sexes:Diagnosis.- Ch 36. Pharmacotherapy and other conservative treatments.- Ch 37. Conventional minimally invasive and surgical treatments.- Ch 38. New surgical treatments.- Ch 39. New experimental treatments.- Part 10: Chronic pelvic pain.- Ch 40. Chronic Pelvic Pain.- Part 11: Priapism.- Ch 41. Priapism: Diagnosis and management.- Part 12: Penile curvature.- Ch 42. Penile Curvature: Diagnosis and Management.- Part 13: Male infertility.- Ch 43. Male infertility: Diagnosis and management.- Ch 44. Testosterone Physiology and the Diagnosis of Male Hypogonadism.- Ch 45. Testosterone and sexual function.- Ch 46. Practical perspectives in testosterone treatment.- Ch 47. Testosterone and the prostate.- Ch 48. Testosterone, metabolism, and the cardiovascular system.- Part 14: Male sexual dysfunction.- Ch 49. Erectile dysfunction.- Ch 50. Premature Ejaculation.- Ch 51. Acquired Penile Curvature.- Ch 52. Hypogonadism.- Part 15: Urological infections.- Ch 53. Asymptomatic bacteriuria.- Ch 54. Uncomplicated cystitis.- Ch 55. Recurrent cystitis.- Ch 56. Catheter-associated UTIs.- Ch 57. Pyelonephritis.- Ch 58. Prostatitis.- Ch 59. Epididymitis.- Ch 60. Urethritis.- Ch 61. Fournier's Gangrene Or Necrotizing Fasciitis Of The Perineum And External Genitalia.- Ch 62. Urosepsis.- Ch 63. Antimicrobial Prophylaxis.- Part 16: Urolithiasis.- Ch 64. Urinary Stones- Risk of Formation, Diagnosis and Initial Management.- Ch 65. Surgical interventions for urinary stone disease including SWL and indications for active stone removal.- Ch 66. The Role of Medical Treatment to Urinary Stone Clearance and Recurrence.- Part 17: Urological trauma.- Ch 67. General principles and management.- Ch 68. Renal and Ureteric Trauma.- Ch 69. Bladder Trauma.- Ch 70. Current Management Of Urinary Tract Injuries.- Ch 71....